Colgate-Palmolive (NYSE:CL) Shares Bought by Pitcairn Co.

Pitcairn Co. grew its holdings in shares of Colgate-Palmolive (NYSE:CL) by 8.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,388 shares of the company’s stock after purchasing an additional 787 shares during the period. Pitcairn Co.’s holdings in Colgate-Palmolive were worth $1,078,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in CL. 1832 Asset Management L.P. increased its stake in Colgate-Palmolive by 4,847.3% during the 1st quarter. 1832 Asset Management L.P. now owns 9,301 shares of the company’s stock valued at $838,000 after purchasing an additional 9,113 shares in the last quarter. Industrial Alliance Investment Management Inc. increased its holdings in shares of Colgate-Palmolive by 4.4% in the first quarter. Industrial Alliance Investment Management Inc. now owns 4,185 shares of the company’s stock valued at $377,000 after purchasing an additional 176 shares during the period. B. Riley Wealth Advisors Inc. raised its stake in shares of Colgate-Palmolive by 0.8% in the first quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock worth $1,498,000 after purchasing an additional 138 shares during the last quarter. California State Teachers Retirement System raised its stake in shares of Colgate-Palmolive by 0.8% in the first quarter. California State Teachers Retirement System now owns 1,301,518 shares of the company’s stock worth $117,202,000 after purchasing an additional 9,979 shares during the last quarter. Finally, Tidal Investments LLC boosted its position in Colgate-Palmolive by 31.1% in the first quarter. Tidal Investments LLC now owns 61,646 shares of the company’s stock valued at $5,551,000 after buying an additional 14,631 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE CL opened at $94.92 on Monday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock’s 50 day simple moving average is $98.10 and its 200-day simple moving average is $98.57. The company has a market cap of $77.55 billion, a PE ratio of 27.20, a price-to-earnings-growth ratio of 3.36 and a beta of 0.42. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.11%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analyst Upgrades and Downgrades

CL has been the subject of several research reports. Morgan Stanley lifted their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. Sanford C. Bernstein increased their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the company from $105.00 to $101.00 in a report on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their target price for the stock from $107.00 to $109.00 in a report on Monday, September 9th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.